## EXPD: Expeditors International of Was - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 4.90 fails VALUE criteria (<1.0); RSI 70 overbought. Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.7% MRS), overbought RSI (70).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($140.10)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Expeditors International of Washington, Inc. $EXPD Shares Acquired by Prudential Financial Inc.**
- Source: MarketBeat | 20251130T105005 | Neutral | Relevance: 99%
-  Prudential Financial Inc. increased its stake in Expeditors International of Washington, Inc. by 7.2%, acquiring an additional 5,537 shares for a total of 82,596 shares valued at $9.44 million. The article also details recent insider selling by Director Mark A. Emmert and VP Jeffrey F. Dickerman, as well as the company's dividend announcement and various analyst ratings which collectively give the stock a "Hold" consensus.

**2. State Board of Administration of Florida Retirement System Reduces Stock Position in Expeditors International of Washington, Inc. $EXPD**
- Source: MarketBeat | 20251202T111022 | Neutral | Relevance: 99%
- The State Board of Administration of Florida Retirement System decreased its holdings in Expeditors International of Washington by 2.2% in Q2 2025, selling 3,373 shares but still retaining a significant stake worth approximately $17.53 million. While some insiders sold shares, several other institutional investors, such as First Eagle Investment Management LLC and Boston Partners, significantly increased their positions in EXPD. The article also details recent stock performance, a dividend announcement, and updated analyst ratings, reflecting a mixed sentiment with a consensus "Hold" rating.

**3. 15 High Quality Dividend Stocks for Long-Term Investors**
- Source: Insider Monkey | 20251130T231400 | Bullish | Relevance: 99%
- This article identifies Expeditors International of Washington, Inc. (NYSE:EXPD) as a high-quality dividend stock for long-term investors, highlighting its strong financial performance in Q3 2025 and strategic expansion. BofA raised its price target on EXPD to $150 and maintained a Neutral rating, citing increased EPS forecasts due to stronger-than-expected demand in customs and airfreight, especially benefiting from AI infrastructure investments by technology customers. The company also repurchased $212 million in common stock and returned $725 million to shareholders year-to-date through buybacks and dividends.

**4. Expeditors International (EXPD): Assessing Valuation After Analyst Upgrades and Earnings Outlook Boost**
- Source: Yahoo! Finance Canada | 20251201T000900 | Bullish | Relevance: 99%
- Expeditors International (EXPD) has seen significant stock momentum following analyst upgrades and a boosted earnings outlook. While its current Price-to-Earnings (P/E) ratio of 23.3x suggests overvaluation compared to industry peers, a Discounted Cash Flow (DCF) model indicates the stock might be undervalued by approximately 22%. Investors are prompted to consider these differing valuation perspectives.

**5. UPS vs. EXPD: Which Dividend-Paying Stock Reigns Supreme Currently?**
- Source: TradingView | 20251202T172129 | Bullish | Relevance: 99%
- This article compares UPS and Expeditors International (EXPD), two dividend-paying transportation stocks, during a period of economic uncertainty. While both increased dividends, UPS's dividend sustainability is questioned due to its high payout ratio and declining free cash flow, unlike EXPD. EXPD is highlighted as a more attractive investment due to stronger price performance, improving airfreight landscape, and better earnings estimates despite its higher valuation.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $95 | $90 | +6% |
| 2025-11-17 | UBS | $166 | $138 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Underweight |
| 2025-11-17 | UBS | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-0.9%)
- Blackrock Inc.: 9.2% (-10.1%)
- State Street Corpora: 5.8% (+5.1%)
- First Eagle Investme: 4.7% (+0.0%)
- LOOMIS SAYLES & CO L: 4.3% (+1.6%)

### Key Risks

1. Valuation stretched: PEG 4.9x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.90 signals overvaluation risk, limited margin of safety. Forward P/E 24.6x stretched relative to 2% growth. Quality metrics strong (ROE 36%, ROA 14%). Analyst sentiment positive (2 raises, avg +13%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.5B |
| Beta | 1.14 |
| 52W Range | $100.47 - $151.67 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.90 |
| Forward P/E | 24.6 |
| Current P/E | 24.9 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from 3.1% to -0.6% (-3.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 70, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.59% (CS: 61) | Neutral |
| RSI_14 | 70.3 | Overbought |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.140x | Above |
| vs SMA200 | 1.231x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $146.48
- **Stop Loss:** $140.10 (4.4% risk)
- **Target:** $152.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 78
- **Position Value:** $11,425.44
- **Portfolio %:** 11.43%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-24 (Est: $1.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.39 | $1.64 | +18.1% |
| 2025Q2 | $1.24 | $1.34 | +7.9% |
| 2025Q1 | $1.35 | $1.47 | +9.1% |
| 2024Q4 | $1.44 | $1.68 | +16.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*